Related Experiment Video
Updated: Jun 13, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Insulin resistance, diabetes and cognitive function: consequences for preventative strategies
I Bourdel-Marchasson1, E Lapre, H Laksir
1UMR 5536 CNRS, University V.-Segalen Bordeaux 2, Bordeaux, France. isabelle.bourdel-marchasson@chu-bordeaux.fr
Diabetes & Metabolism
|May 18, 2010
Summary
Metabolic syndrome and diabetes are linked to cognitive decline and dementia. Lifestyle interventions may help prevent age-related cognitive changes, but drug trials have shown limited success.
Area of Science:
- Neurology
- Endocrinology
- Gerontology
Background:
- Cognitive decline and dementia pose significant burdens on patients and families.
- Metabolic syndrome, with or without diabetes, is associated with executive dysfunction and slower psychomotor speed.
- Diabetes is a known risk factor for various dementias, including vascular dementia.
Purpose of the Study:
- To explore the relationship between metabolic syndrome, diabetes, and cognitive decline.
- To review the effectiveness of interventions for preventing age-related cognitive changes.
Main Methods:
- Review of epidemiological studies on diabetes and dementia risk.
- Analysis of drug interventional trials for metabolic syndrome and cognitive decline.
- Consideration of lifestyle interventions for cognitive health.
Main Results:
- Metabolic syndrome and diabetes are linked to poorer cognitive function.
- The role of metabolic syndrome in Alzheimer's disease risk requires further investigation.
- Current drug intervention trials for preventing cognitive decline via metabolic syndrome have yielded disappointing results.
Conclusions:
- Lifestyle interventions are crucial for preventing age-related cognitive decline, particularly in middle-aged and younger-elderly populations.
- Further research is needed to understand the mechanisms linking metabolic syndrome and cognitive alterations.
- Preventative strategies should focus on broader population health, including lifestyle modifications.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...